BRCA1 and ovarian cancer: For example, in Ashkenazi Jewish (AJ) population, three BRCA1/2 (BRCA) pathogenic variants (PVs) with founder effect are responsible for 10% of breast cancers (BC) and 40% of ovarian cancers (OC) [3].